Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
Shelley Harris
Kidney International, 2013
View PDFchevron_right
Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
Mohd Fauzi
PLOS ONE, 2019
View PDFchevron_right
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
Marisa Martin
2021
View PDFchevron_right
Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study
jan willem cohen tervaert
American journal of clinical pathology, 2014
View PDFchevron_right
Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
Vivekanand Jha
Kidney International Reports, 2017
View PDFchevron_right
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
Hanna Debiec
PloS one, 2017
View PDFchevron_right
Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more
Bahar Bastani
Journal of Nephropathology
View PDFchevron_right
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
Marilina Tampoia
Journal of Nephrology, 2020
View PDFchevron_right
Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy – a retrospective cohort study
Dimitra Kalavrizioti
Romanian Journal of Internal Medicine
View PDFchevron_right
Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods
Mark Haas
Clinical Nephrology, 2015
View PDFchevron_right
Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy
Sanjeev Sethi
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015
View PDFchevron_right
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy
Joel Polidori
Journal of the American Society of Nephrology : JASN, 2015
View PDFchevron_right
Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy
Ana Matas
Clinical Kidney Journal, 2018
View PDFchevron_right
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
Andreea Andronesi
BioMed Research International, 2015
View PDFchevron_right
ANTI-PLA2R ANTIBODY AND PRIMARY MEMBRANOUS NEPHROPATHY: A LITERATURE REVIEW (Atena Editora)
Atena Editora
ANTI-PLA2R ANTIBODY AND PRIMARY MEMBRANOUS NEPHROPATHY: A LITERATURE REVIEW (Atena Editora), 2023
View PDFchevron_right
Anti-phospholipase A2 receptor antibodies in the diagnosis of idiopathic membranous nephropathy
H. Viana
View PDFchevron_right
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients
Laetitia Albano
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014
View PDFchevron_right
Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
Henry HL Wu
Clinical Kidney Journal, 2022
View PDFchevron_right
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
F. Fervenza
Journal of the American Society of Nephrology, 2011
View PDFchevron_right
Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings
Saime Paydas
International Journal of Clinical Practice, 2020
View PDFchevron_right
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era
Rivka Ayalon
Pediatric Nephrology, 2019
View PDFchevron_right
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
Pierre Ronco, Vladimir Tesar, Hanna Debiec
Nephrology Dialysis Transplantation, 2013
View PDFchevron_right
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases
Francesca Pregnolato
Journal of Nephrology, 2017
View PDFchevron_right
Rituximab in the treatment of PLA2R-associated membranous nephropathy: Insights from a hospital centre experience
mica pomper
2024
View PDFchevron_right
Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience
sonia mehrotra
Journal of Renal Injury Prevention
View PDFchevron_right
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
P. van Paassen, jan willem cohen tervaert
American Journal of Kidney Diseases, 2013
View PDFchevron_right
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
Baoli Liu
Frontiers in Immunology, 2019
View PDFchevron_right
Faculty of 1000 evaluation for M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
David Goldsmith
F1000 - Post-publication peer review of the biomedical literature, 2009
View PDFchevron_right
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
P. Ronco
Journal of the American Society of Nephrology, 2012
View PDFchevron_right